Skip to main content
Article thumbnail
Location of Repository

Apigenin Induces Apoptosis through a Mitochondria/Caspase-Pathway in Human Breast Cancer MDA-MB-453 Cells

By Eun Jeong Choi and Gun-Hee Kim

Abstract

In this study, we investigated the mechanistic role of the caspase cascade in extrinsic and intrinsic apoptosis induced by apigenin, which has been targeted as a candidate in the development of noncytotoxic anticancer medicines. Treatment with apigenin (1–100 µM) significantly inhibited the proliferation of MDA-MB-453 human breast cancer cells in a dose- and time-dependent manner with IC50 values of 59.44 and 35.15 µM at 24 and 72 h, respectively. This inhibition resulted in the induction of apoptosis and the release of cytochrome c in cells exposed to apigenin at its 72 h IC50. Subsequently, caspase-9, which acts in mitochondria-mediated apoptosis, was cleaved by apigenin. In addition, apigenin activated caspase-3, which functions downstream of caspase-9. The apigenin-induced activation of caspase-3 was accompanied by the cleavage of capases-6, -7, and -8. These results are supported by evidence showing that the activity patterns of caspases-3, -8, and -9 were similar. The present study supports the hypothesis that apigenin-induced apoptosis involves the activation of both the intrinsic and extrinsic apoptotic pathways

Topics: Original Article
Publisher: the Society for Free Radical Research Japan
OAI identifier: oai:pubmedcentral.nih.gov:2675027
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2001). Apigenin acts on the tumor cell invasion process and regulates protease production.
    2. (2008). Apigenin causes G(2)/M arrest associated with the modulation of p21(Cip1) and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells.
    3. (2008). Apigenin, a dietary flavonoid, sensitizes human T cells for activation-induced cell death by inhibiting PKB/Akt and NF-kappaB activation pathway. Immunol Lett., Epub ahead of print,
    4. (2006). Apigenin: is it a pro- or antiinflammatory agent?
    5. (2001). Biological properties of citrus flavonoids pertaining to cancer and inflammation.
    6. (2005). Cancer gene therapy: strategies and clinical trials.
    7. (2008). Cancer phytotherapeutics: role for flavonoids at the cellular level.
    8. (2000). Caspase-8 in apoptosis: the beginning of “the end”?
    9. (2004). Caspases and cancer: mechanisms of inactivation and new treatment modalities.
    10. (2002). Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines.
    11. (2005). Daidzein-sulfate metabolites affect transcriptional and antiproliferative activities of estrogen receptor-beta in cultured human cancer cells.
    12. (2002). Down-regulation of osteoclast differentiation by daidzein via caspase 3.
    13. (2007). Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention.
    14. (2008). Enhancement of UVB-induced apoptosis by apigenin in human keratinocytes and organotypic keratinocyte cultures.
    15. (2006). Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy.
    16. (2008). Flavones and flavonols exert cytotoxic effects on a human oesophageal adenocarcinoma cell line (OE33) by causing G2/M arrest and inducing apoptosis. Food Chem.
    17. (2001). Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) content of edible tropical plants.
    18. (2003). Flavonoids: promising anticancer agents.
    19. (2005). Induction of caspase-dependent, p53-mediated apoptosis by apigenin in human neuroblastoma.
    20. (2004). Inhibitory effect of genistein and daidzein on ovarian cancer cell growth.
    21. (1990). Isolation and studies of the mutagenic activity in the Ames test of flavonoids naturally occurring in medical herbs.
    22. (2006). Prostatic fluid concentrations of isoflavonoids in soy consumers are sufficient to inhibit growth of benign and malignant prostatic epithelial cells in vitro.
    23. (2004). Protective role of Apigenin on the status of lipid peroxidation and antioxidant defense against hepatocarcinogenesis in Wistar albino rats.
    24. (2005). Recent advances in understanding the cell death pathways activated by anticancer therapy.
    25. (1993). Skin anti-inflammatory activity of apigenin-7-glucoside in rats.
    26. (2001). Study of antioxidant effect of apigenin, luteolin and quercetin by DNA protective method.
    27. (2006). The flavonoid apigenin inhibits the proliferation of prostatic stromal cells via the MAPK-pathway and cellcycle arrest
    28. (2001). The role of caspase-8 in resistance to cancer chemotherapy. Drug resis.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.